The HCPLive endocrinology page is a comprehensive resource for clinical news and insights on endocrine system conditions. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for diabetes, hormonal disease, and more.
November 16th 2024
Reducing systolic blood pressure to less than 120 mmHg lowered the risk of major cardiovascular events for most people with diabetes in the BPROAD trial.
HCPLive Endocrinology's flagship diabetes podcast, hosted by Diana Isaacs, PharmD, and Natalie Bellini, DNP
Potential Discovery of Pancreatic Cancerous Cell Mechanisms
January 28th 2015Researchers at Huntsman Cancer Institute (HCI) at the University of Utah recently discovered the mechanism potentially triggering pancreatic cancer from the defects resulting from extrusion, the process through which cells are squeezed out of overcrowded tissue to die.
Critical Illness and Renal Clearance: Why So Fast?
January 27th 2015Renal clearance can be significantly elevated in the critically ill. Treating these patients with renally cleared drugs can present a problem. Drugs-whisked through the body with greater than expected efficiency, a process called augmented renal clearance (ARC)-reach only suboptimal levels and, consequently, patients experience no improvement or actual clinical decline. ARC is often associated with elevated urinary creatinine clearance.
Rogue Breast Cancer: The Triple Negative Dilemma
January 27th 2015In March 2014, the Society of Surgical Oncology Susan G. Komen for the Cure Symposium focused on the literature on the epidemiology, molecular pathology, and therapy considerations of triple-negative breast cancer. The Annals of Surgical Oncology has published a summary of this work ahead of print.
PTSD May Elevate Risk of Type 2 Diabetes Mellitus in Women
January 27th 2015JAMA Psychiatry has published a study ahead of print examining the relationship between PTSD and T2DM in Nurses' Health Study II participants. The study questioned whether PTSD increased the risk of T2DM among civilians, and the magnitude of change. The findings indicated a positive association.
Fasting Blood Glucose and Pancreatic Cancer: Possible Link
January 19th 2015The incidence and mortality of pancreatic adenocarcinoma, the fourth leading cause of cancer deaths in the United States, are both on the rise. Globally, the disease is responsible for 227,000 deaths annually. Researchers from the National Taiwan University College of Medicine recently published a meta-analysis that demonstrated a dose-response relationship between fasting blood glucose levels and pancreatic cancer risk. They also examined the link between prediabetes and pancreatic cancer risk.
Exercise Timing in Patients with Diabetes: Maximizing Metabolic Benefit
January 19th 2015Researchers at the University of Missouri and the National Research Council in Padova, Italy, recently investigated the role that timing of resistance exercise plays in lowering cardiovascular risk. They wondered if the time of day when diabetics exercise could explain the lower-than-expected exercise-derived benefits seen in some diabetics.
Bone Mineral Density Loss is Not Significantly Different Among Pre and Postmenopausal Women
There is no difference in bone mineral density loss among pre- and postmenopausal women with rheumatoid arthritis, according to research from the Babol University of Medical Sciences in Iran.
Research Shows Diabetes Patients Living Longer
Researchers in Scotland have shown that while diabetes is a growing problem for that country's population, patients diagnosed with the condition are living considerably longer than they would have in the past. This is particularly true for patients diagnosed with type 1 diabetes.
Metformin: Multitasking Medicine
January 12th 2015Tuberculosis (TB) kills 1.43 million people annually. Effective TB treatment is challenging, due to the mycobacterial cell wall's unusual structure and chemical composition -- the wall repels drugs efficiently and renders many antibiotics ineffective. An article in Science Translational Medicine describes a drug that may have potential to alter host response to TB: the antidiabetic agent metformin.
What's the Story with Statins and Stroke Prevention? - A Q&A with Koto Ishida, MD
There have been some disappointing studies and contradictory recommendations on using statins to treat stroke. HCPLive's Gale Scott interviewed Koto Ishida, MD, medical director of the NYU Langone Comprehensive Stroke Care Center, about the implications for clinicians.
Diabetic Polyneuropathy: Is Pain a Component?
January 7th 2015Diabetic polyneuropathy (DPN) can exist with or without neuropathic pain. Roughly half of patients with types I and II diabetes mellitus (DM) develop DPN. In type 1 DM, patients start to notice symptoms of distal polyneuropathy after many years of chronic prolonged hyperglycemia. It's more aggressive in type 2 DM, and can develop after only a few years of known poor glycemic control and may be present at diagnosis.
Healthy Resolutions Show Benefits Long After New Year's Eve
With a new year comes New Year's resolutions, many of which involve getting healthy in the year ahead. A recent study has shown that by keeping those resolutions people can not only lose the weight they want but also avoid other health issues like diabetes.
Search for Diabetes Cure Highlights Top Stories of 2014
December 30th 2014Obesity and physical activity have become a focus of the healthcare community in the recent past and that was no exception in 2014. Over the past 12 months we have highlighted advancements in the treatment, diagnosis and impact of diabetes on our daily lives. Here is a look at the top 10 stories from the year.
Diagnosing and Treating Diabetes: The Difficulties of Subtype
December 23rd 2014As many as 15% of diabetics may be misdiagnosed with simple diabetes mellitus (DM) types 1 or 2. But DM presents as more than 50 unique types, and even among correctly diagnosed type 2 patients, 60 predisposing genetic variants exist.
FDA Approves New Weight-Management Drug
December 23rd 2014Saxenda (liraglutide [rDNA origin] injection) 3 mg has been approved as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in obese and overweight adults who have at least one weight-related comorbidity.
Dangerous Liaisons: Elder Abuse and Metabolic Syndromes
December 22nd 2014Around 10% of elders experience some form of elder abuse (physical, sexual or emotional abuse; neglect, exploitation, or abandonment), and elders who are abused appear to have a high level of comorbidity. Evidence suggests that patients who have experienced elder abuse are at higher risk of cardiovascular-related mortality.